In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market.
Tag: Beta Amyloid
Is everything we think we know about Alzheimer’s wrong?
Beta-amyloid is far from the only factor in dementia, memory loss and Alzheimer’s disease, and far from the only target for drugs, says the director of a top Alzheimer’s center. Research on many molecules, and an emphasis on preventing or slowing the disease, are both crucial.
Evidence Mounts for Alternate Origins of Alzheimer’s Disease Plaques
A breakdown in how brain cells rid themselves of waste precedes the buildup of debris-filled plaques known to occur in Alzheimer’s disease, a new study in mice shows.